Senior Clinical Scientist Lead — GI Drug Development (RSU)

Ironwood Pharmaceuticals, Inc.; Boston (MA); On-site; USD 147,000 - 175,000; Full time

Benefits offered by this job

Restricted Stock Units

Bonus eligibility

401(k) with matching

Medical, dental, vision benefits

Wellness stipends

Vacation/holiday schedule

Job summary

Ironwood Pharmaceuticals, a Boston-based GI-focused company, seeks a Clinical Research Scientist to lead day-to-day clinical science coordination across assigned studies, partnering with Clinical Operations, Biostatistics and Data Management.

You will contribute to protocol development, data review and regulatory support, with Medical Director retaining medical oversight. Travel up to 20% with Basel or Boston site considerations.

Qualifications

• BS/BSN required; MS/PhD preferred.
• At least five years in clinical drug development.
• Experience with protocol development, data review and regulatory support.
• Strong leadership, communication and cross-functional collaboration.

Responsibilities

• Serve as the day-to-day clinical science contact for assigned studies.
• Lead study planning, protocol development and data interpretation with cross-functional teams.
• Coordinate cross-functional study execution and issue escalation with Clinical Operations, Biostatistics and Data Management.
• Provide clinical input to regulatory responses and study reports.
• Maintain up-to-date knowledge of disease area, GCP, and regulatory requirements.

Skills

Clinical trial design

Cross-functional collaboration

GCP compliance

English fluency

Education

Bachelor's in life sciences

Advanced degree preferred

Job description

Ironwood Pharmaceuticals, a Boston-based GI-focused company, seeks a Clinical Research Scientist to lead day-to-day clinical science coordination across assigned studies, partnering with Clinical Operations, Biostatistics and Data Management.

You will contribute to protocol development, data review and regulatory support, with Medical Director retaining medical oversight. Travel up to 20% with Basel or Boston site considerations.